Arabcofloroquin

Ciprofloxacin Lactate 2mg/ml

Solution for I.V Infusion

Product Details

Each vial contains 232.88 mg Ciprofloxacin Lactate Equivalent to 200 mg Ciprofloxacin.

Solution for I.V infusion

Arabcofloroquin solution for infusion is indicated for the treatment of the following infections.

Lower respiratory tract infections due to Gram-negative bacteria
- exacerbations of chronic obstructive pulmonary disease
- Broncho-pulmonary infections in cystic fibrosis or in bronchiectasis
- Pneumonia
Chronic suppurative otitis media
Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria
Urinary tract infections
Genital tract infections
- Epididymo-orchitis including cases due to susceptible Neisseria gonorrhoeae
- Pelvic inflammatory disease including cases due to susceptible Neisseria gonorrhoeae
Infections of the gastro-intestinal tract (e.g. travelers’ diarrhea)
Intra-abdominal infections
Infections of the skin and soft tissue caused by Gram-negative bacteria
Malignant external otitis
Infections of the bones and joints
Inhalation anthrax (post-exposure prophylaxis and curative treatment)

Ciprofloxacin may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.

Broncho-pulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa
Complicated urinary tract infections and pyelonephritis
Inhalation anthrax (post-exposure prophylaxis and curative treatment)
Ciprofloxacin may also be used to treat severe infections in children and adolescents when this is considered to be necessary.
Treatment should be initiated only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents.

For dosage details leaflet available upon request.

Carton box containing glass vial containing 100 ml solution and an inner leaflet.

Store at temperature not exceeding 30°C
After opening, use for only 7 days and store at temperature 2-8 °C